作者: Michael S. Radin
DOI: 10.1007/S11606-013-2595-X
关键词:
摘要: Since the beginning of clinical use in 1970s, hemoglobin A1c (A1c) has become standard tool for monitoring glycemic control patients with diabetes. The role test was broadened 2010, when American Diabetes Association added as a diagnostic criterion Because A1c’s integral diagnosis and treatment, it is important to recognize scenarios interfering factors that yield false results. purpose this review describe measurement, outline or may results, alternative laboratory biomarkers.